By vgreene, 22 October, 2020 Avifavir for Treatment of Patients With Moderate COVID 19 Interim Results of a Phase II III Multicenter Randomized Clinical Trial access Clin Infect Dis article
By vgreene, 22 October, 2020 Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID 19 Patients An Exploratory Randomized Controlled Trial access pre print medRxiv article
By vgreene, 22 October, 2020 A Prospective Randomized Open Label Trial of Early Versus Late Favipiravir in Hospitalized Patients With COVID 19 access Antimicrob Agents Chemother article
By vgreene, 22 October, 2020 Study considerations non randomized open label study excl older and severe pts possible historical bias relationship btwn viral titer and clinical prognosis not well defined
